Concepedia

Michael H. Reutershan

MH

Statistics

Publications

8

Citations

286

H-Index

8

Active since

2007

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Bowdoin College

Michael H. Reutershan is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

ORCID

Publications per year

2007–2021

8

Publications

8

Asymmetric Michael addition of α-nitro-ketones using catalytic peptides

Brian R. Linton, Michael H. Reutershan, Christopher M. Aderman et al. · Tetrahedron Letters · 2007 · 55 citations

, , +7

Deuterium Exchange as an Indicator of Hydrogen Bond Donors and Acceptors

Lauren R. Steffel, Timothy J. Cashman, Michael H. Reutershan et al. · Journal of the American Chemical Society · 2007 · 52 citations

, , +11

Allosteric Modulation of Protein Arginine Methyltransferase 5 (PRMT5)

R.L. Palte, Sebastian E. Schneider, Michael D. Altman et al. · ACS Medicinal Chemistry Letters · 2020 · 39 citations · Full text

, , +17

Purine derivatives as potent γ-secretase modulators

Alexey Rivkin, Sean P. Ahearn, Stephanie M. Chichetti et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 35 citations · Full text

, , +11

The Discovery of Two Novel Classes of 5,5-Bicyclic Nucleoside-Derived PRMT5 Inhibitors for the Treatment of Cancer

Ryan V. Quiroz, Michael H. Reutershan, Sebastian E. Schneider et al. · Journal of Medicinal Chemistry · 2021 · 34 citations · Full text

, , +15

1–5 of 8